Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.63 USD -3.31%
Market Cap: 775m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Operating Expenses Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Expenses
-$275.2m
CAGR 3-Years
-53%
CAGR 5-Years
-96%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Expenses
-CA$10m
CAGR 3-Years
-1%
CAGR 5-Years
-39%
CAGR 10-Years
-39%
Replicel Life Sciences Inc
XTSX:RP
Operating Expenses
-CA$1.7m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
7%
Innovotech Inc
XTSX:IOT
Operating Expenses
-CA$1.4m
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-2%

See Also

What is Abcellera Biologics Inc's Operating Expenses?
Operating Expenses
-275.2m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Operating Expenses amounts to -275.2m USD.

What is Abcellera Biologics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-96%

Over the last year, the Operating Expenses growth was -2%. The average annual Operating Expenses growth rates for Abcellera Biologics Inc have been -53% over the past three years , -96% over the past five years .

Back to Top